HEADLINES

Indian Market
Indian equity markets up by 2.62% . Nifty up by 142.30 pts and settle at 5577.65 Sensex up by 443.11 pts at 18464.27 Bank Nifty up by 435.10 pts at 10642.90

DAILY EQUITY NEWSLETTER

17 SEPTEMBER 2012
TH

Global Market
European markets were up with FTSE up by 96.47 pts at 5916.39 ,CAC up by 73.71 pts at 3575.80 and DAX up by 108.97 pts at 7419.29 Dow future up by 60.00 pts at 13580.00

HEADLINES
Bharti Infratel files DRHP, Bharti Airtel to stay away . SBI sees no case for further CRR cut Now. August inflation shoots up to 7.5% versus 6.87% in July. Big bang reforms: Government to consider FDI in multi-brand retail, aviation.

WWW.EPICRESEARCH.CO

09993959693

 MARKET ANALYSIS:
Key benchmark indices scaled fresh 7-month highs as pivotals extended gains in late trade. A steep hike of Rs 5 per liter on heavily subsidised diesel by the Cabinet Committee on Political Affairs (CCPA) on Thursday to bring down the burgeoning fiscal deficit and sustained buying by foreign funds bolstered sentiment. The BSE Sensex was up 420 points or 2.33% to 18,441.16. The index surged 477.38 points at the day's high of 18,498.54 in late trade. The S&P CNX Nifty was up 132.05 points or 2.43% to 5,567.40. The index hit an intraday high of 5,586.65, its highest level since 22 February 2012. Among the 30-share Sensex pack, 24 gained and only six of them declined. Markets across the globe surged after the US central bank on Thursday initiated another aggressive stimulus program to stimulate growth in the world's largest economy. Index heavyweight Reliance Industries (RIL) gained 5.05% to Rs 838.60. ICICI Bank surged 4.76% after the private sector bank cut deposit rates by 50 basis points and the revised rates were effective 11 September 2012.

FIIs and DIIs

CATEGORY DATE BUY SELL NET

STOCKS TO WATCH JUBILANT FOODS AURO PHARMA AMBUJA ARVIND

FII DII

14-Sep-12 14-Sep-12

5355.25 1818.41

2521.53 2506.41

2833.72 -688

NIFTY DAILY PIVOTS

PIVOT NIFTY R4 5743 R3 5683 R2 5623 R1 5600 PP 5563 S1 5540 S2 5503 S3 5443 S4 5383

SCRIPS IN BAN PERIOD

COREEDUTEC HDIL MCDOWELL-N SUZLON WELCORP JET AIRWAYS

WWW.EPICRESEARCH.CO

09993959693

-GAINERS AND LOOSERS

EXPERT OPINION
NIFTY

DAILY NIFTY GAINERS

SCRIPS RATE VOL. (000) PR. CLOSE NET CHAN GE % CHANGE

Nifty looks Bullish Strategy: Buy on dips Support:5540

9.15 8.03

Jindal Steel
Hindalco

373.20 118.35 216.60 73.70 1009.90

8390.12 18890.28 7827.03 22440.47 4716.53

341.90 109.55 202.00 69.15 948.05

31.30 8.80 14.60 4.55 61.85

Resistance: 5612
BANK NIFTY

Bank Nifty looks Bullish

7.23 6.58 6.52

DLF JP Assoc Axis Bank

Strategy: Buy on dips Support:10580 Resistance:10710

PREVIOUS PERFORMANCE
DAILY NIFTY LOOSERS
SCRIPS RATE VOL. (000) PR. CLOSE NET % CHAN GE TYPE SCRIP B/S RESULT

CASH CASH FUTURE FUTURE

ARVIND CAIRN INDIA AMBUJA BHARTI AIRTEL

B B B S

TGT ACHIEVED NOT EXECUTED TGT ACHIEVED NOT EXECUTED

Ranbaxy

540.95

1229.44 467.25 3296.33 4282.18 7604.64

551.25 1778.80 171.15 354.70 121.15

-10.30 -31.30 -2.85 -4.50 -1.15

-1.87 -1.76 -1.67 -1.27 -0.95

Dr Reddys 1747.50 NTPC BPCL Power Grid 168.30 350.20 120.00

www.epicresearch.co

09993959693

MARKET CALLS
CASH
SCRIPS BHARTI AIRTEL DR REDDY ACTION BUY SELL LEVEL 257.30 1739.00 1
ST

TARGET 259.30 1729.00

ND

TARGET 261.80 1715.00

RD

TARGET 264.80 1699.00

STOP LOSS 254.30 1749.00

FUTURE
SCRIPS . AURO PHARMA JUBILANT FOODS ACTION SELL SELL LEVEL 124.40 1234.00 1
ST

TARGET 123.85 1228.00

ND

TARGET 121.85 1220.00

RD

TARGET 120.50 1210.00

STOP LOSS 124.95 1240.00

Disclaimer
The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of NSE and BSE. The share price projections shown are not necessarily indicative of future price performance. The information herein, togethe r with all estimates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocks recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for . Any surfing and reading of the information is the acceptance of this disclaimer. All Rights Reserved. Investment in equity & bullion market has its own risks. We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoev er for any financial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer to buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our calls or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then Serious Legal Actions can be taken.